The association between neuroblastoma and opsoclonus-myoclonus syndrome: a historical review

@article{Rothenberg2009TheAB,
  title={The association between neuroblastoma and opsoclonus-myoclonus syndrome: a historical review},
  author={Alexis B. Rothenberg and Walter E. Berdon and Giulio J D'angio and Darrell J. Yamashiro and Robert A. Cowles},
  journal={Pediatric Radiology},
  year={2009},
  volume={39},
  pages={723-726}
}
An association between neuroblastoma and opsoclonus-myoclonus syndrome (OMS) was described as early as 1927 within the first report on the transformation of malignant neuroblastoma to a benign ganglioneuroma. It was not recognized at that time nor was it appreciated in the subsequent follow-up report on the same patient in 1959. Myoclonic encephalopathy of infancy, an alternative name for OMS, was described by a pediatric neurologist in 1962; however, its connection to neuroblastoma was not… Expand
Síndrome opsoclonus mioclonus paraneoplásico en pediatría: reporte de caso y revisión de la literatura
TLDR
The case of a girl of 15 months with OMS associated with retroperitoneal ganglioneuroblastoma that improved after tumor resection and treatment with corticosteroids and immunoglobulin is presented. Expand
Update on opsoclonus–myoclonus syndrome in adults
TLDR
This review focuses on underlying mechanisms of opsoclonus–myOClonus syndrome, including findings that have been identified recently, and provides an update on the clinical features and treatments of this condition. Expand
The opsoclonus–myoclonus syndrome
TLDR
The clinical features, diagnosis, pathogenesis and management of opsoclonus–myoclonuses syndrome are described, which may represent a non-metastatic manifestation of neuroblastoma in children and small cell carcinoma of the lung in adults. Expand
Caso clínico: síndrome opsoclonus-mioclonus asociado a un neuroblastoma abdominal
TLDR
A case diagnosed at nine month of age, treated in the Unit and refered for a multidisciplinary neuropsychological rehabilitation when she was 4 year old, reports onOpsoclonus-ataxia. Expand
[A case report on cervical neuroblastoma with ataxia].
TLDR
It is suggested that neuroblastoma should be considered in any child with unexpected by prolonged ataxia, particularly in children associated with Opsoclonus-myOClonus syndrome. Expand
Update on paraneoplastic neurological syndromes
TLDR
There is increasing recognition of an extensive array of PNS and of several paraneoplastic antibodies as biological markers of these disorders and basic immunological studies support the pathogenic role of some of these antibodies. Expand
Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study
TLDR
A major clinical challenge is to increase OMS recognition, prevent initial misdiagnosis, and shorten time to diagnosis/treatment. Expand
Resonancia magnética de cuerpo entero en un caso de neuroblastoma abdominal oculto con síndrome opsoclonus-myoclonus
TLDR
This work presents the case of a two-year-old boy with signs of opsoclonus-myOClonus syndrome in whom a retroperitoneal neuroblastoma was detected by whole-body MRI. Expand
A rare cause of chronic ataxia in childhood: ganglioneuroma
TLDR
A 4-year-old-boy presented with wide-base gait over the previous 2 years and recently described hand tremor when reaching out for an object, which identified the tumor as ganglioneuroma, and underwent complete resection. Expand
Neuroblastoma of the Iris in Children.
TLDR
It is suggested that neonates and infants who are diagnosed as having neuroblastoma undergo an ophthalmologic examination after the initial diagnosis to investigate the true incidence of small iris lesions in Neuroblastoma that may have been unrecognized. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 25 REFERENCES
Neuroepidemiologic Trends in 105 US Cases of Pediatric Opsoclonus-Myoclonus Syndrome
TLDR
Tumor resection alone did not provide adequate therapy for most children with OMS, and Adrenocorticotropic hormone, prednisone, and intravenous immunoglobulin were used with equal frequency, but ACTH was associated with the best early response. Expand
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
TLDR
Comparing the outcome of neuroblastoma patients with and without OMA, relating to prognostic factors, treatment, and the presence or absence of anti-neuronal antibodies found a significant correlation with lower stage disease compared to more advanced disease. Expand
Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases
TLDR
Ganglioneuroblastoma, intermixed subtype, lack of MYCN amplification, aneuploid DNA content and presence of lymphoid infiltrates may contribute to favorable prognosis in NTs associated with OMS. Expand
Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus.
TLDR
Results suggest that MIBG may prove to be a useful screening procedure in patients with IME, and traditional imaging modalities can then be directed to evaluate sites of disease identified by M IBG scans. Expand
Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.
TLDR
Persistent neurologic deficits are characteristic for children with neuroblastoma and opsoclonus-myoclonu and treatment with chemotherapy may improve the neurologic outcome. Expand
Opsoclonus and occult neuroblastoma.
TLDR
Two children with opsoclonus and occult neuroblastoma were seen on the Pediatric Neurology Service of Columbia–Presbyterian Medical Center, with one of them chiefly affecting the brain-stem. Expand
The association of neuroblastoma and myoclonic encephalopathy: an imaging approach
TLDR
An imaging approach that includes chest radiography and abdominal computed tomography (CT) is suggested that may be required in selected patients with myoclonic encephalopathy. Expand
Metaiodobenzylguanidine total-body scintigraphy required for revealing occult neuroblastoma in opsoclonus-myoclonus syndrome
Abstract. A girl aged 13 months presented with clinical features of subacute progressive ataxia leading to abasia, astasia, loss of unsupported sitting and apraxia. In addition, an opsoclonus,Expand
The immunopharmacology of the opsoclonus-myoclonus syndrome.
TLDR
Recent clinical and laboratory evidence for the autoimmune theory is surveyed and how some current therapies for OMS may exert their effects through immunomodulation is discussed, providing possible new directions for immunologic research and therapy in OMS. Expand
Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
TLDR
The increased deficits in older children raise concern that this represents a progressive encephalopathy rather than a time-limited single insult, but the study was unable to confirm a purported advantage of either ACTH over corticosteroids or of cyclophosphamide. Expand
...
1
2
3
...